Blocking costimulatory signal for treating steroid-resistant asthma model
A. Mori, A. Abe, S. Kouyama, M. Yamaguchi, M. Enoki, Y. Iijima, C. Mitsui, C. Oshikata, H. Tanimoto, Y. Fukutomi, K. Sekiya, M. Taniguchi, Y. Maeda, M. Ohtomo, M. Hasegawa, K. Akiyama, T. Ohtomo, O. Kaminua (Sagamihara, Tokyo, Japan)
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mori, A. Abe, S. Kouyama, M. Yamaguchi, M. Enoki, Y. Iijima, C. Mitsui, C. Oshikata, H. Tanimoto, Y. Fukutomi, K. Sekiya, M. Taniguchi, Y. Maeda, M. Ohtomo, M. Hasegawa, K. Akiyama, T. Ohtomo, O. Kaminua (Sagamihara, Tokyo, Japan). Blocking costimulatory signal for treating steroid-resistant asthma model. Eur Respir J 2012; 40: Suppl. 56, 2321
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Source: Eur Respir J 2007; 30: 383-390 Year: 2007
IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
T-cell co-stimulatory molecules: their role in allergic immune reactions Source: Eur Respir J 2007; 29: 1246-1255 Year: 2007
Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Plasma concentrations of costimulatory molecules are altered in children with chronic stable asthma Source: Eur Respir J 2005; 26: Suppl. 49, 616s Year: 2005
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011
TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
Cellular mechanisms underlying steroid-resistant asthma Source: Eur Respir Rev, 28 (153) 190096; 10.1183/16000617.0096-2019 Year: 2019
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006
Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Expression of interleukin-4 receptor in bronchial asthma patients treated with specific immunotherapy (SIT) Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002
Notch pathway signaling in asthma Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006
Interleukin-17 cytokine signalling in patients with asthma Source: Eur Respir J 2014; 44: 1319-1331 Year: 2014
The immunological features of the severe steroid-resistant asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
CTLA4-Ig enhanced glucocorticoid effect on murine asthma Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
Allergen specific immunotherapy induces T-cell anergy via upregulating CTLA-4 and downregulating CD86 in a murine OVA-sensitized model Source: Eur Respir J 2004; 24: Suppl. 48, 349s Year: 2004
MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007
The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003